Venetoclax-obinutuzumab in frontline and R/R CLL: Outcomes compared to age- and sex-matched general population
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Lauren Pomerantz, Sameer Parikh, Kari Rabe, Paul Hampel, Lindsey Roeker, Saad Kenderian, Neil Kay, Rachel Bailen, Amber Koehler, Catherine Coddington, Amy Behnken, Jose Leis, Talal Hilal, Mazie Tsang, Ricardo Parrondo, Susan Schwager, Sara Achenbach, Cinthya Mendoza Zepeda, Min Shi, Curtis Hanson, Susan Slager, Esteban Braggio, Yucai Wang
Institutions: Mayo Clinic, Mayo Clinic in Florida
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417014302
Cites:
Cited by:
Related to: